BCN-HS-PEG2-VA-PABC-SG3199
BCN-HS-PEG2-VA-PABC-SG3199 (Compound 4) is a pyrrolobenzodiazepine (PBD) -based linker-drug for constructing antibody-drug conjugates (ADCs) . Its BCN group enables bioorthogonal conjugation via SPAAC click chemistry with azides, facilitating the development of targeted therapies for cancer research in both in vitro and in vivo models.
Product Specifications
CAS Number
2126805-05-6
Field of Research
Metabolism Research
Smiles
C (OCC1=CC=C (NC ([C@@H] (NC ([C@@H] (NC (COCCOCCNS (NC (OC[C@@H]2[C@]3 ([C@@]2 (CCC#CCC3) [H]) [H]) =O) (=O) =O) =O) [C@@H] (C) C) =O) C) =O) C=C1) (=O) N4C=5C (C (=O) N6[C@] ([C@@H]4O) (CC (C) =C6) [H]) =CC (OC) =C (OCCCCCOC7=C (OC) C=C8C (=C7) N=C[C@]9 (N (C8=O) C=C (C) C9) [H]) C5
Molecular Formula
C66H83N9O18S
Molecular Weight
1322.48
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog